OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LANSOPRAZOL ABZ- PHARMA 15 MG, 30 MG, GASTRO-RESISTANT CAPSULES, HARD (see Annex I) Lansoprazol AbZ-Pharma 15 mg, 30 mg, gastro-resistant capsules, hard were referred for arbitration according to Article 29 of Council Directive 2001/ 83/ EC, as amended, following concerns raised by Germany during a Mutual Recognition Procedure with Finland acting as Reference Member state.
SPLOŠNI POVZETEK ZNANSTVENEGA VREDNOTENJA ZDRAVILA LANSOPRAZOL ABZ- PHARMA 15 MG, 30 MG, GASTROREZISTENTNE KAPSULE, TRDE (glejte Dodatek I) Zdravilo Lansoprazol AbZ- Pharma 15- mg, 30- mg gastrorezistentne kapsule, trde, je bilo napoteno na arbitražni postopek v skladu s členom 29 Direktive Sveta 2001/ 83/ ES, kakor je bila spremenjena, zaradi zadržkov, ki jih je predložila Nemčija v okviru postopka medsebojnega priznavanja s Finsko, ki je bila referenčna država članica.